Concepedia

Publication | Closed Access

Sclerostin is not associated with cardiovascular event or fracture in kidney transplantation candidates

DOI

16

Citations

0

References

2018

Year

Hanne Skou Jørgensen, Simon Winther, Laust Dupont, Morten Bøttcher, Lars Rejnmark, Ellen‐Margrethe Hauge, My Svensson, Per Ivarsen
Clinical Nephrology

Abstract

Sclerostin was positively associated with the presence of vascular calcifications, but was not predictive of events associated with mineral and bone disorder in a cohort of kidney transplantation candidates. .